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Abstract 
A convenient gold-catalyzed asymmetric synthesis of polysubstituted furfurylamines 
starting from amino acids has been achieved. The cyclization proceeded under mild 
conditions and generally provided the furan or iodofuran derivatives in good to excellent 
yields and high enantiomeric excess. Iodofurans were validated as good intermediates for 
classical organometallic coupling reactions. 
 
1. Introduction 
Polysubstituted furans are key structural units found in many natural products1 and 
pharmaceuticals.2 Thus, several methods for their synthesis have been developed in the past 
few years,3 including transition-metal-mediated cyclizations and cycloisomerizations.4  
Optically active 2-aminomethyl-furans have important applications as chiral ligands or 
organocatalysts,5 and as building blocks for various biologically active molecules6 and 
provide access to many nitrogen containing compounds such as piperidines or aza-sugars -by 
the aza-Achmanowicz rearrangement-7 or amino acids by oxidative cleavage.8 However, few 
stereoselective syntheses of chiral furfurylamines have been described and most of them 
involve the modification of substituted furans, such as the asymmetric aminohydroxylation of 
vinylfuran or the enantioselective reduction of furanyl ketones.9 Thus, the search for efficient, 
convenient and highly stereoselective alternative synthetic routes is of great interest. 
We have previously reported diverse gold-catalyzed approaches to nitrogen containing 5-
or 6- membered heterocycles from amino acids.10 We herein report an efficient synthetic route 
to some chiral di- and tri-substituted aminomethylfuran derivatives from α-aminoalkynyl-
1,2-diols prepared from commercially available amino-acids. Our synthetic approach is 
outlined in scheme 1. 
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Scheme 1. Retrosynthetic strategy. 
The structural diversity of commercially available enantiopure amino acids and the 
opportunity for late-stage diversification at intermediate diol 3 should allow rapid generation 
of enantioenriched 2-amino furan libraries by this strategy. One major advantage of gold 
catalyzed cyclization is minimal racemization under the very mild conditions. 
 
2. Results and discussion  
Our initial efforts focused on the synthesis of the key intermediates acetylenic diols 3, 
precursors of chiral 2-aminomethylfurans 1 or 2 by gold-catalyzed dehydrative cyclization. 
We first prepared aldehydes 4a-d on a gram scale in two steps from commercially available 
N-Boc protected amino acids. Amino acids were converted to their corresponding Weinreb 
amides using TBTU, DIEA and N,O-dimethylhydroxylamine hydrochloride in DMF, then 
reduced without any racemization using lithium aluminium hydride in diethylether at -15°C 
according to a published procedure.11 The observed optical rotation of these derivatives 4 
were in agreement with the literature.12  
Intermediates enynes 6 were obtained from aldehydes 4 by one step (Wittig reaction, 
Method A) or two steps (Takai iodovinylation13 then Sonogashira coupling reaction, Method 
B) routes (Scheme 2). 
Wittig reaction of 4a-b with 2-pentynyltriphenylphosphonium bromide and n-BuLi in 
THF afforded amino enynes 6a-b in moderate yield as a mixture of diastereoisomers (E/Z: 
80/20).14 Method B is a more general strategy due to the wide variety of commercially 
available terminal alkynes. Trans vinyl iodides 5 were obtained by treatment of aldehydes 4 
with iodoform in the presence of CrCl2,
15 and  Sonogashira coupling16 of 1-pentyne or 
phenylacetylene in the presence of PdCl2(PPh3)2 yielded enynes 6c-d (51-67 % yield over two 
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steps). The trans geometry of the vinyl iodides 5 was confirmed by the coupling constant of 
the two vinylic protons (J = 14.5 Hz). 
 
Scheme 2. Synthesis of enyne intermediates 6. 
 
We next focused on the dihydroxylation17 of alkenes 6a-d to obtain dihydroxy alkynes 3 
(Scheme 3). Osmium tetroxide and N-methylmorpholine N-oxide failed to deliver the 
expected diols 3, but modified Sharpless asymmetric dihydroxylation conditions with 
additional methane sulfonamide18 allowed the isolation of the diols 3a-d in a range of 72-79 
% yield. The use of AD-mix-easier to manipulate and methane sulfonamide in t-
BuOH:H2O (1:1) gave best yields. 
 
 
Scheme 3.  Dihydroxylation of intermediates 6. 
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With these diols 3 in hands, we next turned our attention to their gold-catalyzed 
dehydrative cyclization into di-substituted furans 1 and 4-iodofurans 2 using reaction 
conditions that were successful in our previous work (Scheme 4).10  
In order to validate this cyclization, diol 3a was treated with PPh3AuCl (1 mol%) and 
AgSbF6 (1 mol%) in 1,2-dichloroethane (1,2-DCE) at room temperature to afford furan 1a in 
89% yield in 1 h.  As expected, no reaction was observed when AgSbF6 or PPh3AuCl 
catalysts were used separately.  
Iodocyclization was next investigated. The reaction of 3a with NIS or I2 as electrophilic 
halogen sources in the absence of a catalyst returned either starting 3a or complex mixtures 
with only traces 2a. Catalytic iodocyclization under conditions previously developed in our 
laboratory19 revealed that the use of PPh3AuCl (1 mol%) in the presence of AgSbF6 (1 mol%), 
with NIS (1.2 eq) as electrophile, in 1,2-DCE at room temperature, afforded furan 2a in 62% 
yield in 1 h (Scheme 3). Similar treatment of enantiomeric 3b allowed purity measurement of 
1a-b and 2a-b (93-96% ee) by chiral HPLC, which indicated minimal ee erosion during the 
sequence. 
Various α,-dihydroxyalkynes 3 were submitted to our reaction conditions to generate 
series of disubstituted furans 1 and iodofurans 2 in moderate to excellent yields (Scheme 4). 
 
Scheme 4.  Gold-catalyzed cyclization of substrates 3 to furans 1 and 2. 
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The value of iodo-furans 2 as chiral building blocks was demonstrated by further 
manipulation using Suzuki-Miyaura,20 Heck,21 Sonogashira22 and Buchwald-Hartwig23 
couplings (Scheme 5). Compounds 7-9 were obtained in excellent isolated yields (87-94%) by 
Suzuki-Miyaura cross-coupling reaction of 2 with arylboronic acids. Heck and Sonogashira 
reactions of 2c with ethyl acrylate or phenylacetylene respectively provided adducts 10 and 11 
in 60% and 94% isolated yields. Finally, Buchwald-Hartwig amination of 2d with tert-
butylcarbamate gave the corresponding aminofuran 12, albeit in low yield. 
 
 
 
 
Scheme 5. Reagents and conditions: Suzuki-Miyaura coupling reaction (i) Ar-B(OH)2, K3PO4, S-Phos 
(10 mol%), Pd(OAc)2 (5 mol%), toluene, 80°C, 3 h; Heck coupling reaction (ii) Methyl acrylate, TEA, 
Pd(PPh3)4 (10 mol%), DMF, 80°C, 2 h; Sonogashira coupling reaction (iii) Phenylacetylene, 
PdCl2(PPh3)2 (1 mol%), CuI (2 mol%),  TEA, rt, 4 h; Buchwald-Hartwig coupling reaction (iv) tert-
Butyl carbamate, Cs2CO3, CuI (20 mol%), N,N‘-DMEDA (40 mol%), toluene, 90°C, 18 h. 
 
Access to fully deprotected -amino alcohol derivatives by our strategy was then 
investigated.  Efficient hydrogenolysis of the benzyl groups in 1a and 7 was accomplished 
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with cyclohexene in the presence of Pearlman’s catalyst to give 13 and 14 with an excellent 
enantiomeric excess (Scheme 6).  
 
 
 
Scheme 6. Removal of protecting groups and access to amino-alcohol derivatives 
 
Finally, N-Boc deprotection of 13 with 4M HCl in dioxane proceeded smoothly to give -
amino alcohol 15 in 72% yield. 
 
3. Conclusion  
In conclusion, we have reported a convenient gold-catalyzed approach for the synthesis of 
polysubstituted aminomethyl-furan derivatives from chiral acetylenic diol intermediates. The 
reaction proceeds under mild conditions, generally providing furan products in good to 
excellent yields and enantiopurity. Such compounds may have applications as chiral ligands, 
organocatalysts and pharmaceuticals.   
 
 
4. Experimental 
 
4.1 General  
All reagents of high quality were purchased from commercial suppliers, and used without 
further purification. All reactions requiring anhydrous conditions were performed under an 
argon atmosphere using oven dried glassware. DMF and THF were distilled from CaH2 and 
Na/benzophenone, respectively. 1H and 13C NMR were recorded at 300 and 75 MHz 
respectively on a Bruker AM 300 spectrometer, using CDCl3 (and TMS as internal standard). 
 values are given in parts per million (ppm), coupling constants (J values) are given in Hertz 
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(Hz), and multiplicity of signals are reported as follows: s, singlet; d, doublet; t, triplet; q, 
quadruplet; m, multiplet; bs, broad singlet. Thin layer chromatography was performed using 
precoated silica gel plate (0.2 mm thickness). Infrared spectra were recorded using an 
Universal Attenuated Total Reflectance Accessory (UATR). All melting points are 
uncorrected. Optical rotations were measured at the sodium D line on a digital polarimeter at 
ambient temperature.  
 
4.2 Typical procedure for the preparation of vinyl iodides 5  
Chromium(II) chloride (2.22 g, 18.0  mmol) was suspended in dry THF (25 mL) at room 
temperature under argon. A solution of aldehyde 4c or 4d (4.0 mmol) and iodoform (2.37 g, 
6.0 mmol) in THF (25 mL) was added dropwise. After stirring in the dark  at room 
temperature for 2 h, the reaction mixture was hydrolysed with a satured solution of NH4Cl (50 
mL) and extracted with diethylether (3 × 40 mL). The combined organic layers were washed 
with brine, then dried over magnesium sulfate, concentrated and purified by silica gel 
chromatography (2% ethyl acetate in dichloromethane) to afford the products 5c and 5d as a 
mixture of isomers E/Z, ratio: 90/10. 
 
4.2.1 tert-Butyl (R,E)-(4-iodo-1-phenylbut-3-en-2-yl)carbamate 5c 
 970 mg (65%). Data of the separated major isomer E: white solid, mp = 108-109 °C; 
[α]D22= + 23.8 (c 1.04, CH2Cl2); IR (UATR): 3351, 1687, 1612 cm-1; 1H NMR (300  MHz, 
CDCl3): δ 7.34-7.21 (m, 3H), 7.17-7.14 (m, 2H), 6.47 (dd, J = 14.5 Hz, J = 5.9 Hz, 1H),  6.19 
(dd, J = 14.5 Hz,   J = 1.2 Hz, 1H), 4.47 (bs, 1H), 4.39 (bs, 1H), 2.82 (bd, J = 6.6 Hz, 2H), 
1.40 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 155.0, 145.5, 136.7, 129.6, 128.7, 126.9, 80.0, 
77.5, 55.9, 41.2, 28.4; HRMS (ESI, m/z): Calcd. for C15H20NO2INa: 396.0437, found 
[M+Na]+: 396.0437.    
 
4.2.2 (S,E/Z)-2-(2-Iodovinyl)pyrrolidine-1-carboxylic acid tert-Butyl ester 5d 
870 mg (67%), pale yellow oil. Data of the mixture of  isomers: IR (UATR): 1687, 1607   
cm-1; spectroscopic data for the unseparated major isomer E: 1H NMR (300  MHz, CDCl3, 50 
°C): δ 6.42 (dd, J = 14.4 Hz, J = 6.5 Hz, 1H),  6.14 (d, J = 14.4 Hz, 1H), 4.24 (bs, 1H), 3.38 
(t, J = 6.6 Hz, 2H), 2.05-1.90 (m, 1H), 1.89-1.69 (m, 3H), 1.44 (s, 9H); 13C NMR (75 MHz, 
8 
 
CDCl3, 50 °C): δ 154.5, 146.5, 79.7, 76.1, 61.3, 46.4, 31.4, 28.7, 23.3; HRMS (ESI, m/z): 
Calcd. for C11H18NO2INa: 346.0280, found [M+Na]
+: 346.0283. 
 
4.3 Typical procedure for the preparation of enynes 6 
4.3.1 From aldehydes 4 (Method A)  
To a stirred suspension of 2-pentynyltriphenylphosphonium bromide14 (1.43 g, 3.5 mmol) 
in 18 mL of dry THF at -78 °C under argon atmosphere was added dropwise 1.7 mL (3.5 
mmol) of a 2.1 M solution of n-butyllithium in hexane. After stirring at -78 °C for 1 h, a 
solution of N-Boc-L-serinal 4a or N-Boc-D-serinal 4b (0.98 g, 3.5 mmol) in 15 mL of dry 
THF was added. After stirring at -78 °C for 30 min, the mixture was allowed to warm to room 
temperature over 2 h. Then 40 mL H2O was added and the mixture was extracted with 
diethylether (3 × 40mL). The combined organic extracts were washed with brine, dried over 
magnesium sulfate and concentrated. Chromatography on silica gel, eluting with 2% 
diethylether in dichloromethane gave 6a or 6b. 
 
4.3.1.1 tert-Butyl (S,E)-(1-(benzyloxy)oct-3-en-5-yn-2-yl)carbamate 6a 
650 mg (56%), pale yellow oil, as a mixture of E/Z isomers, ratio: 80/20. Data of the 
separated major E isomer: [α]D22= -29.0 (c 1.05, CHCl3); IR (HATR): 3337, 2216, 1698, 1633 
cm-1; 1H NMR (300  MHz, CDCl3): δ 7.39-7.27 (m, 5H), 6.03 (dd, J = 15.9 Hz, J = 6.1 Hz, 
1H),  5.68 (dm, J = 15.9 Hz, 1H), 4.88 (bs, 1H), 4.52 (s, 2H), 4.34 (bs, 1H), 3.54 (dd, J = 9.5 
Hz, J = 4.4 Hz, 1H), 3.47 (dd, J = 9.5 Hz, J = 4.5 Hz, 1H), 2.30 (qd, J = 7.5 Hz, J = 2.1 Hz, 
1H), 1.44 (s, 9H), 1.15 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 155.3, 139.7, 137.9, 
128.6, 127.9, 127.8, 111.8, 92.7, 79.8, 77.8, 73.4, 72.0, 52.1, 28.5, 14.0, 13.2; HRMS (ESI, 
m/z): Calcd. for C20H27NO3Na: 352.1888, found [M+Na]
+: 352.1884. 
 
4.3.1.2 tert-Butyl (R,E)-(1-(benzyloxy)oct-3-en-5-yn-2-yl)carbamate 6b 
 650 mg (56%), pale yellow oil. Data of the separated major E isomer: [α]D22= +27.1 (c 
0.93, CHCl3); spectral data and HRMS are identical with those reportated for 6a. 
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4.3.2 From vinyl iodides 5 (Method B)  
To a degassed solution of vinyl iodide 5c or 5d (2.5 mmol) and  triethylamine (0.7 mL, 5 
mmol)  in 25 mL EtOH were added successively under argon atmoshere, PdCl2(PPh3)2 (17.5 
mg, 0.025mmol, 1 mol%), CuI (23.8 mg, 0.125 mmol, 5 mol%) and the appropriate alkyne 
(2.75 mmol). The mixture was stirred 72 h for 6c and 24 h for 6d at room temperature. After 
the reaction was completed (1H NMR analysis), 50 mL H2O was added and the mixture was 
extracted with diethylether (3 × 40mL). The combined organic extracts were washed with 
brine, dried over magnesium sulfate and concentrated. Chromatography on silica gel, eluting 
with 20% cyclohexane  in dichloromethane gave 6c-d as a mixture of E/Z isomers, 
ratio:90/10. 
 
4.3.2.1 tert-Butyl (R,E)-(1-phenylnon-3-en-5-yn-2-yl)carbamate 6c 
 780 mg (78%). Data of the separated major E isomer: brown solid, mp = 84-85 °C; IR 
(UATR): 3354, 2219, 1687, 1603 cm-1; 1H NMR (300  MHz, CDCl3): δ 7.33-7.16 (m, 5H), 
5.96 (dd,   J = 15.9 Hz, J = 5.5 Hz, 1H), 5.56 (dm, J = 15.9 Hz, 1H), 4.44 (bs, 2H), 2.82 (bd, J 
= 5.9 Hz, 2H), 2.25 (td, J = 7.0 Hz, J = 2.1 Hz, 2H), 1.53 (sext, J = 7.2 Hz, 2H), 1.39 (s, 9H), 
0.97 (t, J = 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 155.1, 141.3, 137.2, 129.6, 128.6, 
126.7, 111.0, 91.2, 79.7, 78.5, 53.0, 41.6, 28.5, 22.3, 21.5, 13.7; HRMS (ESI, m/z): Calcd. for 
C20H27NO2Na: 336.1939, found [M+Na]
+: 336.1938. 
 
4.3.2.2 (S,E)-2-Hept-1-en-3-yn-1-yl)pyrrolidine-1-carboxylic acid tert-butyl ester 6d 
740 mg (100%), orange solid, mp = 86-87 °C. Data of the mixture of  isomers: IR 
(UATR): 1688, 1594 cm-1; spectroscopic data for the unseparated major E isomer: 1H NMR 
(300  MHz, CDCl3, 50 °C): δ 7.42-7.40 (m, 2H), 7.30-7.25 (m, 3H), 6.10 (dd, J = 15.7 Hz, J = 
6.2 Hz, 1H),  5.74 (d, J = 15.9 Hz, 1H), 4.36 (bs, 1H), 3.49-3.32 (m, 2H), 2.08-2.01 (m, 1H), 
1.92-1.79 (m, 2H), 1.77-1.72 (m, 1H), 1.46 (s, 9H); 13C NMR (75 MHz, CDCl3, 50 °C): δ 
154.6, 144.1, 131.7, 128.4, 128.2, 123.8, 109.8, 89.9, 87.8, 79.6, 58.8, 46.5, 32.2, 28.7, 23.4; 
HRMS (ESI, m/z): Calcd. for C19H23NO2Na: 320.1626, found [M+Na]
+: 320.1622. 
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4.4 Typical procedure for the preparation of diols 3 
To a solution of enynes 6a-d (2.0 m mol) in t-BuOH/H2O (1:1, 26 mL) were added 
successively at 0°C AD-mix-β (2.8 g, 1.4 g/mmol of substrate) , a solution of 0.05% (w/v) 
OsO4 in t-BuOH (6 mL, 0.012 mmol), NaHCO3 (0.5 g, 6.0 mmol) and methanesulfonamide 
(0.38 g, 4 mmol). The mixture was stirred vigorously at 0°C 48 h for 3a-c and 24 h for 3d. 
The reaction was quenched with Na2S2O3 (3 g) maintaining vigorous agitation for 30 min at 
0°C. Diethylether (20 mL) was added and the mixture was warmed to room temperature 
under constant agitation. The organic layer was separated and the aqueous layer was extacted 
with diethylether (3 × 40 mL). The combined organic layers were washed with brine, dried 
over magnesium sulfate and concentrated. Chromatography on silica gel (20% ethyl acetate in 
dichloromethane for 3a, 3b and 3d, 30% ethyl acetate in dichlorometane for 3c) afforded  the 
dihydroxylated derivatives 3a-d as a mixture of diastereomers used in the next step without 
separation. 
 
4.4.1 tert-Butyl ((2S)-(1-(benzyloxy)-3,4-dihydroxyoct-5-yn-2-yl)carbamate 3a 
550 mg (76%), pale yellow oil. Data of the separated major dihydroxylated product: 
[α]D22= + 31.6 (c 1.01, CH2Cl2); IR (HATR): 3389, 2289, 2232, 1682 cm-1; 1H NMR (300  
MHz, CDCl3): δ 7.38-7.28 (m, 5H), 5.15 (bd, J = 8.7 Hz, 1H), 4.54 (s, 2H), 4.34 (bd, J = 7.5 
Hz, 1H), 4.12-4.01 (m, 1H), 3.84 (bd, J = 6.2 Hz, 1H), 3.74-3.56 (m, 2H), 3.51(bs, 1H), 
2.94(bs, 1H), 2.22 (qd, J = 7.5 Hz, J = 1.8 Hz, 2H), 1.44 (s, 9H), 1.13 (t, J = 7.5 Hz, 3H); 13C 
NMR (75 MHz, CDCl3): δ 156.3, 137.7, 128.6, 128.0, 127,8, 89.1, 80.0, 76.9, 75.1, 73.5, 
71.2, 64.0, 50.7, 28.5, 13.8, 12.6; HRMS (ESI, m/z): Calcd. for C20H29NO5Na: 386.1943, 
found [M+Na]+: 386.1945.  
 
4.4.2 tert-Butyl ((2R)-(1-(benzyloxy)-3,4-dihydroxyoct-5-yn-2-yl)carbamate 3b 
520 mg (72%), pale yellow oil. Data of the separated major dihydroxylated product: 
[α]D22= + 3.4 (c 1.35, CHCl3); IR (HATR): 3400, 2287, 2233, 1682 cm-1; 1H NMR (300  
MHz, CDCl3): δ 7.40-7.28 (m, 5H), 5.29 (bd, J = 7.4 Hz, 1H), 4.57 (AB System, JAB = 11.7 
Hz, 1H), 4.51 (AB System, JAB = 11.7 Hz, 1H), 4.48-4.43 (m, 1H), 3.95 (d, J = 9.5 Hz, 1H), 
3.73-3.61 (m, 3H), 3.02 (bs, 2H), 2.24 (qd, J = 7.5 Hz, J = 2.0 Hz, 2H), 1.44 (s, 9H), 1.15 (t, J 
= 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 157.1, 137.8, 128.6, 128.0, 127,8, 88.2, 80.7, 
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74.1, 73.7, 69.2, 62.9, 51.6, 28.4, 13.8, 12.6; HRMS (ESI, m/z): Calcd. for C20H29NO5Na: 
386.1943, found [M+Na]+: 386.1945.                                                                     
 
4.4.3 tert-Butyl ((2R)-3,4-dihydroxy-1-phenylnon-5-yn-2-yl)carbamate 3c 
 520 mg (75%). Data of the separated major dihydroxylated product: cream solid, mp = 
108-109 °C; [α]D22= + 23.9 (c 0.78, CH2Cl2); IR (UATR): 3566, 3348, 2227, 1688 cm-1; 1H 
NMR (300  MHz, CDCl3): δ 7.35-7.22 (m, 5H), 4.60 (bd, J = 8.6 Hz, 1H), 4.46-4.42 (m, 1H), 
3.96-3.82 (m, 1H), 3.82 (bd, J = 4.4 Hz, 1H), 3.47-3.38 (m, 1H), 3.09 (dd, J = 14.0 Hz, J = 
4.1 Hz, 1H), 2.97-2.90 (m,  1H), 2.91 (bd, J = 6.0 Hz, 1H), 2.22 (td, J = 7.1 Hz, J = 2.0 Hz, 
2H), 1.55 (sext, J = 7.3 Hz, 2H), 1.37 (s, 9H), 0.98 (t, J = 7.3 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 157.1, 137.4, 129.6, 128.8, 126.8, 87.1, 80.7, 78.0, 76.0, 63.1, 52.6, 36.5, 28.4, 
22.1, 20.9, 13.7; HRMS (ESI, m/z): Calcd. for C20H29NO4Na:370.1994, found [M+Na]
+: 
370.1991.  
 
4.4.4 (2R)-2-(1,2-Dihydroxyhept-3-yn-1-yl)pyrrolidine-1-carboxylic acid  tert-butyl ester 
3d 
520 mg (79%), pale yellow oil. Data of the separated major dihydroxylated product:  
[α]D22= -100.2 (c 1.31, CH2Cl2); IR (UATR): 3381, 2243, 1658 cm-1; 1H NMR (300  MHz, 
CDCl3): δ 7.47-7.43 (m, 2H), 7.32-7.27 (m, 3H), 5.21 (bs, 1H), 4.62-4.53 (m, 1H), 4.13 (td, J 
= 7.6 Hz, J = 3.6 Hz, 1H), 3.73-3.67 (m, 2H), 3.57-3.49 (m, 1H),  3.38-3.30 (m, 1H), 2.12-
1.80 (m, 4H), 1.46 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 158.4, 132.0, 128.5, 128.3, 122.7, 
88.2, 85.3, 81.2, 78.2, 64.5, 59.6, 47.7, 29.2, 28.5, 24.3; HRMS (ESI, m/z): Calcd. for 
C19H25NO4Na: 354.1681, found [M+Na]
+: 354.1681. 
 
4.5 Typical procedure for the synthesis of furans 1 
 To a degassed solution of dihydroxylated derivatives 3a-c (0.6 mmol) in 1,2-
dichloroethane (4 mL) was added under argon atmosphere 0.4 mL of a freshly prepared 
solution of PPh3AuCl (14.8 mg, 0.03 mmol) and AgSbF6 (10.3 mg, 0.03mmol) in 2 mL 
degassed 1,2- dichloroethane. After stirring for 1 h at room temperature, the reaction mixture 
was concentrated and purified by silica gel chromatography eluting with dichloromethane to 
afford the 2,5-disubstitued furans 1a-c. 
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4.5.1 tert-Butyl (S)-(2-(benzyloxy)-1-(5-ethylfuran-2-yl)ethyl)carbamate 1a 
184 mg (89%), colorless oil. [α]D22= -35.1 (c 1.00, CH2Cl2), 94% ee; IR (UATR): 3336, 
1705 cm-1; 1H NMR (300  MHz, CDCl3): δ 7.38-7.24 (m, 5H), 6.11 (d, J = 3.1 Hz, 1H), 5.89 
(dt, J = 3.1 Hz, J = 0.9 Hz, 1H), 5.08 (bs, 1H), 4.93 (bs, 1H), 4.55 (AB System, JAB = 12.1 
Hz, 1H), 4.49 (AB System, JAB = 12.1 Hz, 1H), 3.76 (dd, J = 9.7 Hz, J = 4.9 Hz, 1H), 3.70 
(dd, J = 9.7 Hz, J = 5.0 Hz, 1H), 2.60 (q, J = 7.5 Hz, 2H), 1.44 (s, 9H), 1.20 (t, J = 7.5 Hz, 
3H); 13C NMR (75 MHz, CDCl3): δ 157.3, 155.4, 151.1, 138.1, 128.5, 127.8, 127.7, 107.2, 
104.7, 79.8, 73.2, 71.0, 48.9, 28.5, 21.5, 12.2; HRMS (ESI, m/z): Calcd. for C20H27NO4Na: 
368.1832, found [M+Na]+: 368.1833; HPLC analysis (Chiralpak IA column, heptane/2-
propanol = 95/5, flow rate = 1 mL/min, wavelength = 230 nm): Rt =7.42 (major) and 8.22 
(minor).                                                                                                                                        
 
4.5.2 tert-Butyl (R)-(2-(benzyloxy)-1-(5-ethylfuran-2-yl)ethyl)carbamate 1b 
184 mg (89%), colorless oil. [α]D22= +33.4 (c 0.99, CH2Cl2), 93% ee; spectral data and 
HRMS are identical with those reportated for 1a; HPLC analysis (Chiralpak IA column, 
heptane/2-propanol = 95/5, flow rate = 1 ml/min, wavelength = 230 nm): Rt = 7.40 (minor) 
and 8.19 (major).     
 
 
4.5.3 tert-Butyl (R)-(2-phenyl-1-(5-propylfuran-2-yl)ethyl)carbamate 1c 
166 mg (84%), colorless oil. [α]D22= +43.4 (c 1.07, CH2Cl2), ≥ 99% ee; IR (UATR): 3343, 
1701 cm-1; 1H NMR (300  MHz, CDCl3): δ 7.25-7.17 (m, 3H), 7.06-7.03 (m, 2H), 5.88 (d, J = 
3.0 Hz, 1H), 5.84 (d, J = 3.0 Hz, 1H), 4.93 (bs, 1H), 4.82 (bs, 1H), 3.09 (bd, J = 6.6 Hz, 2H), 
2.57 (t, J = 7.4 Hz, 2H), 1.65 (sext, J = 7.4 Hz, 2H), 1.40 (s, 9H), 0.96 (t, J = 7.4 Hz, 3H); 13C 
NMR (75 MHz, CDCl3): δ 155.7, 155.1, 151.9, 137.5, 129.6, 128.3, 126.5, 107.0, 105.5, 79.7, 
50.3, 40.8, 30.2, 28.5, 21.6, 13.8; HRMS (ESI, m/z): Calcd. for C20H27NO3Na: 352.1889, 
found [M+Na]+: 352.1887; HPLC analysis (Chiralpak IA column, heptane/2-propanol = 99/1, 
flow rate = 1 mL/min, wavelength = 220 nm): Rt =10.08. 
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4.6 Typical procedure for the synthesis of iodofurans 2 
 To a degassed solution of dihydroxylated derivatives 3a-d (0.6 mmol) in 1,2-
dichloroethane (4 mL) were added successively under argon atmosphere NIS (0.16 g, 0.72 
mmol) and 0.4 mL of a freshly prepared solution of PPh3AuCl (14.8 mg, 0.03 mmol) and 
AgSbF6 (10.3 mg, 0.03 mmol) in 2 mL degassed 1,2- dichloroethane. After stirring for 1 h at 
room temperature, 20% Na2S2O3  (5 mL) was added and the mixture was extracted with 
diethylether (3 × 10 mL). The combined organic extracts were washed with brine, dried over 
magnesium sulfate and concentrated. Chromatography on silica gel eluting with 
dichloromethane afforded the 2,5-disubstituted 3-iodofurans 2a-d.                                                                                                            
 
4.6.1 tert-Butyl (S)-(2-(benzyloxy)-1-(5-ethyl-4-iodofuran-2-yl)ethyl)carbamate 2a 
175 mg (62%), pale yellow oil. [α]D22= -36.5 (c 1.02, CH2Cl2), 96% ee; IR (UATR): 3332, 
1704 cm-1; 1H NMR (300  MHz, CDCl3): δ 7.37-7.24 (m, 5H), 6.20 (s, 1H), 511 (bs, 1H), 
4.91 (bs, 1H), 4.55 (AB System, JAB = 12.1 Hz, 1H), 4.48 (AB System, JAB = 12.1 Hz, 1H), 
3.75 (dd, J = 9.6 Hz, J = 4.4 Hz, 1H), 3.68 (dd, J = 9.6 Hz, J = 4.7 Hz, 1H), 2.64 (q, J = 7.6 
Hz, 2H), 1.45 (s, 9H), 1.17 (t, J = 7.6 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 157.1, 155.3, 
152.8, 137.9, 128.6, 127.9, 127.8, 114.1, 80.1, 73.3, 70.6, 61.7, 48.8, 28.5, 21.1, 12.6; HRMS 
(ESI, m/z): Calcd. for C20H26NO4INa: 494.0804, found [M+Na]
+: 494.0806; HPLC analysis 
(Chiralpak IA column, heptane/2-propanol = 97/3, flow rate = 1 ml/min, wavelength = 230 
nm): Rt = 9.06 (major) and 9.89 (minor).     
 
4.6.2 tert-Butyl (R)-(2-(benzyloxy)-1-(5-ethyl-4-iodofuran-2-yl)ethyl)carbamate 2b 
  175 mg (62%), pale yellow oil. [α]D22= +36.3 (c 1.03, CH2Cl2), 94% ee; spectral data and 
HRMS are identical with those reportated for 2a; HPLC analysis (Chiralpak IA column, 
heptane/2-propanol = 97/3, flow rate = 1 ml/min, wavelength = 230 nm): Rt = 9.09 (minor) 
and 9.91 (major).     
 
4.6.3 tert-Butyl (R)-(1-(4-iodo-5-propylfuran-2-yl)-2-phenylethyl)carbamate 2c                                                                                                                                                   
153 mg (56%), white solid, mp =79-80 °C; [α]D22= +38.3 (c 1.08, CH2Cl2); IR (UATR): 
3316, 1685 cm-1; 1H NMR (300  MHz, CDCl3): δ 7.28-7.17 (m, 3H), 7.06-7.03 (m, 2H), 6.02 
(s, 1H),  4.95 (bs, 1H), 4.76 (bs, 1H), 3.07 (bd, J = 6.5 Hz, 2H), 2.62 (t, J = 7.4 Hz, 2H), 1.65 
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(sext, J = 7.4 Hz, 2H), 1.40 (s, 9H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 
156.0, 155.0, 153.7, 136.9, 129.5, 128.5, 126.8, 113.9, 80.0, 62.7, 49.9, 40.4, 29.4, 28.4, 21.8, 
13.7; HRMS (ESI, m/z): Calcd. for C20H26NO3INa: 478.0855, found [M+Na]
+: 478.0854.                
                                                                 
4.6.4 (S)-2 -(4-Iodo-5-phenylfuran-2-yl)pyrrolidine-1-carboxylic acid tert-butyl ester 2d 
121 mg (46%), yellow solid, mp = 71-72 °C; [α]D22= -101.0 (c 1.04, CH2Cl2); IR (UATR): 
1690 cm-1; 1H NMR (500  MHz, CDCl3, 55 °C): δ 7.92 (d, J = 7.3 Hz, 2H), 7.39 (t, J = 7.7 
Hz, 2H), 7.30 (t, J = 7.4 Hz, 1H), 6.29 (s, 1H),  4.90 (bs, 1H), 3.59-3.41 (m, 2H), 2.23-2.13 
(m, 1H), 2.12-2.00 (m, 2H), 1.96-1.88 (m, 1H), 1.40 (s, 9H); 13C NMR (125 MHz, CDCl3, 55 
°C): δ 157.1, 154.5, 150.8, 130.6, 128.5, 128.1, 126.3, 116.5, 79.9, 61.2, 54.8, 46.5, 32.4, 
28.6, 23.9; HRMS (ESI, m/z): Calcd. for C19H22NO3INa: 462.0542, found [M+Na]
+: 
462.0540. 
 
4.7 Typical procedure for the Suzuki-Miyaura coupling of iodofurans 2 with 4-
substituted phenylboronic acid 
 To a degassed solution of iodofurans 2a, 2c or 2d  (0.25 mmol) and the appropriate aryl 
boronic acid (0.375 mmol) in toluene (2.5mL) were added successively under argon 
atmosphere K3PO4 (106.0 mg, 0.50 mmol), S-Phos (10.3 mg, 0.025 mmol, 10 mol%) and 
Pd(OAc)2 (2.8 mg, 0.0125 mmol, 5 mol%). The resulting mixture was heated to 80°C for 3 h. 
After cooling, the mixture was diluted with diethylether, filtered over a Celite® plug, wich 
was washed with diethylether. After removal of solvents in vaccuo, the crude product was 
purified by silica gel chromatography eluting with 20% diethylether in petoleum ether for 7, 8 
and 25% ethyl acetate in cyclohexane for 9. 
 
4.7.1 tert-Butyl (S)-(2-(benzyloxy)-1-(5-ethyl-4-(4-fluorophenyl)furan-2-
yl)ethyl)carbamate 7 
96 mg (87%), colorless oil; [α]D22= -36.4 (c 0.99, CH2Cl2), 96% ee; IR (UATR): 3336, 
1711 cm-1; 1H NMR (300  MHz, CDCl3): δ 7.36-7.24 (m, 7H), 7.10-7.02 (m, 2H), 6.28 (s, 
1H), 5.14 (bs, 1H), 4.97 (bs, 1H),  4.58 (AB System, JAB = 12.2 Hz, 1H), 4.52 (AB System, 
JAB = 12.2 Hz, 1H), 3.81 (dd, J = 9.7 Hz, J = 4.6 Hz, 1H), 3.75 (dd, J = 9.7 Hz, J = 4.8 Hz, 
1H), 272 (q, J = 7.5 Hz, 2H), 1.46 (s, 9H), 1.24 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, 
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CDCl3): δ 161.7 (J1CF = 245.3 Hz), 155.4, 152.1, 151.0, 138.1, 130.4 (J4CF = 3.3 Hz), 129.3 
(J3CF = 7.9 Hz), 128.5, 127.8, 127.7, 120.2, 115.5 (J
2
CF = 21.4 Hz), 108.3, 80.0, 73.3, 70.9, 
48.9, 28.5, 20.4, 13.1;   HRMS (ESI, m/z): Calcd. for C26H30NO4FNa: 462.2057, found 
[M+Na]+: 462.2059; HPLC analysis (Chiralpak IA column, heptane/2-propanol = 95/5, flow 
rate = 1 mL/min, wavelength = 220 nm): Rt =10.01 (minor) and 10.70 (major).                                                                                                                                                      
 
4.7.2 tert-Butyl (R)-(1-(4-(4-fluorophenyl)-5-propylfuran-2-yl)-2-phenylethyl)carbamate 
8 
103 mg (95%), colorless oil; [α]D22= +36.6 (c 1.00, CH2Cl2), ≥ 99% ee; IR (UATR): 3345, 
1700 cm-1; 1H NMR (300  MHz, CDCl3): δ 7.26-7.16 (m, 5H), 7.10-7.01 (m, 4H), 6.07 (s, 
1H), 4.99 (bs, 1H), 4.85 (bs, 1H), 3.13 (bd, J = 6.5 Hz, 2H), 2.69 (t, J = 7.5 Hz, 2H), 1.71 
(sext, J = 7.4 Hz, 2H), 1.41(s, 9H), 0.96 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 
161.7 (J1CF = 245.5 Hz), 155.1, 151.8, 151.0, 137.3, 130.4 (J
4
CF = 3.2 Hz), 129.6, 129.3 (J
3
CF 
= 7.9 Hz), 128.4, 126.7, 120.7, 115.5 (J2CF = 21.4 Hz), 108.1, 79.9, 50.1, 40.7, 28.9, 28.5, 
22.1, 14.0; HRMS (ESI, m/z): Calcd. for C26H30NO3FNa: 446.2107, found [M+Na]
+: 
446.2107; HPLC analysis (Chiralpak IA column, heptane/2-propanol = 98/2, flow rate = 1 
mL/min, wavelength = 220 nm): Rt =10.65.                                  
 
4.7.3 (S)-2-(4-(4-((tert-Butoxycarbonyl)amino)phenyl)-5-phenylfuran-2-yl)pyrrolidine-1-
carboxylic acid  tert-butyl ester 9 
119 mg (94%), white solid, mp = 220-221 °C; [α]D22= -86.3 (c 0.91, CH2Cl2), 83% ee; IR 
(UATR): 3247, 1726, 1672 cm-1; 1H NMR (300  MHz, DMSO, 80 °C): δ 9.13 (bs, 1H), 7.48-
7.43 (m, 4H), 7.35-7.30 (m, 2H), 7.27-7.22 (m, 3H), 6.32 (s, 1H), 4.88 (dd, J = 7.7 Hz, J = 2.5 
Hz, 1H), 3.52-3.36 (m, 2H), 2.29-2.16 (m, 1H), 2.11-1.86 (m, 3H), 1.50 (s, 9H), 1.36 (s, 9H); 
13C NMR (75 MHz, DMSO, 80 °C): δ 155.1, 153.1, 152.4, 145.5, 138.4, 130.6, 128.1, 128.0, 
127.1, 127.0, 125.1, 122.2, 118.2, 109.1, 78.8, 78.2, 53.9, 45.7, 31.1, 27.8, 27.7, 23.0; HRMS 
(ESI, m/z): Calcd. for C30H36N2O5Na: 527.2522, found [M+Na]
+: 527.2519; HPLC analysis 
(Chiralpak IA column, heptane/2-propanol = 90/10, flow rate = 1 mL/min, wavelength = 250 
nm): Rt = 7.51 (minor) and 10.27 (major). 
 
4.8 (R,E)-3-(5-(1-((tert-butoxycarbonyl)amino)-2-phenylethyl)-2-propylfuran-3-yl)acrylic 
acid methyl ester 10 
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To a degassed solution of iodofuran 2c (114 mg, 0.25 mmol) in dry DMF (2 mL) were 
added successively under argon atmosphere methyl acrylate (45 µl , 0.5 mmol), triethylamine 
(70 µl, 0.5 mmol) and Pd(PPh3)4 (29 mg, 0.025 mmol, 10 mol%). The mixture was heated to 
80 °C for 2 h. After cooling, H2O (3 mL) was added and the mixture was extracted with 
diethylether (3×5 mL). The combined organic extracts were washed with brine, dried over 
magnesium sulfate and concentrated. Chromatography on silica gel eluting with 2% 
diethylether in dichloromethane afforded the pure product 10 as a yellow solid: 62 mg (60%), 
mp = 104-105 °C; [α]D22= +31.7 (c 0.94, CH2Cl2), 99% ee; IR (UATR): 3343, 1714, 1688, 
1634 cm-1; 1H NMR (300  MHz, CDCl3): δ 7.48 (d, J = 15.7 Hz, 1H), 7.27-7.17 (m, 3H), 
7.06-7.04 (m, 2H), 6.12 (s, 1H), 5.95 (d, J = 15.7 Hz, 1H), 4.97 (bs, 1H), 4.80 (bs, 1H), 3.76 
(s, 3H),  3.09 (bd, J = 6.6 Hz, 2H), 2.69 (t, J = 7.4 Hz, 2H), 1.68 (sext, J = 7.4 Hz, 2H), 1.41 
(s, 9H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 167.9, 158.0, 155.0, 153.6, 
136.9, 135.4, 129.5, 128.5, 126.8, 118.1, 115.8, 104.4, 80.1, 51.6, 50.0, 40.4, 28.5, 28.3, 22.1, 
13.8; HRMS (ESI, m/z): Calcd. for C24H31NO5Na: 436.2100, found [M+Na]
+: 436.2101; 
HPLC analysis (Chiralpak IA column, heptane/2-propanol = 98/2, flow rate = 1 mL/min, 
wavelength = 290 nm): Rt =20.29 (major), 27.17 (minor). 
 
4.9 (R)-(2-Phenyl-1-(4-(phenylethynyl)-5-propylfuran-2-yl)ethyl)carbamic acid tert-butyl 
ester 11 
To a degassed solution of iodofuran 2c (114 mg, 0.25 mmol) in triethylamine (2 mL) were 
added under argon atmoshere PdCl2(PPh3)2 (1.8 mg, 0.0025 mmol, 1 mol%) and CuI (1.0 mg, 
0.005 mmol, 2 mol%). The reaction mixture was stirred for 15 min at room temperature. Then 
a solution of phenylacetylene (69 µl, 0.63 mmol) in triethylamine (0.4 mL) was added 
dropwise and the mixture was stirred for 4 h at room temperature. Subsequently, the mixture 
was diluted with diethylether (10 mL) and washed with brine. The organic extract was 
separated, dried over magnesium sulfate and concentated. Chromatography on silica gel 
eluting with 20% diethylether in petroleum ether afforded the pure product 11 as a pale 
yellow solid: 101 mg (94%), mp = 96-97 °C; [α]D22= +34.2 (c 1.04, CH2Cl2), ≥ 99% ee; IR 
(UATR): 3389, 2223, 1687 cm-1; 1H NMR (300  MHz, CDCl3): δ 7.45-7.43 (m, 2H), 7.35-
7.17 (m, 10H), 7.08-7.05 (m, 2H), 6.06 (s, 1H), 4.96 (bs, 1H), 4.79 (bs, 1H), 3.10 (bd, J = 6.7 
Hz, 2H), 2.74 (t, J = 7.4 Hz, 2H), 1.74 (sext, J = 7.4 Hz, 2H), 1.41 (s, 9H), 0.99 (t, J = 7.4 Hz, 
3H); 13C NMR (75 MHz, CDCl3): δ 159.5, 155.0, 152.1, 137.0, 131.4, 129.5, 128.5, 128.4, 
128.0, 126.7, 123.8, 109.4, 103.7, 91.8, 81.9, 80.0, 50.0, 40.5, 29.3, 28.5, 21.6, 13.9; HRMS 
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(ESI, m/z): Calcd. for C28H31NO3Na: 452.2202, found [M+Na]
+: 452.2205; HPLC analysis 
(Chiralpak IA column, heptane/2-propanol = 98/2, flow rate = 1 mL/min, wavelength = 280 
nm): Rt =10.63. 
 
4.10 (S)-2-(4-((tert-butoxycarbonyl)amino)-5-phenylfuran-2-yl)pyrrolidine-1-carboxylic 
acid tert-butyl ester 12 
To a degassed mixture of iodofuran 2d (110 mg, 0.25 mmol), tert-butyl carbamate (35 
mg, 0.3 mmol), cesium carbonate (122 mg, 0.37 mmol) and CuI (9.5 mg, 0.05 mmol, 20 
mol%) in dry toluene (2.5 mL), was added under argon atmosphere N,N’-DMEDA (11 µl, 0.1 
mmol, 40 mol%). The mixture was heated to 90 °C for 18 h. After cooling, the mixture was 
diluted with dichloromethane, filtered over a Celite plug, which was washed with 
dichloromethane. After removal of solvents in vaccuo, the crude product was purified by 
silica gel chromatography eluting with 5% ethyl acetate in dichloromethane to afford the pure 
product 12 as a colorless oil: 22 mg (20%); [α]D22= -89.0 (c 1.23, CH2Cl2), 97% ee; IR 
(UATR): 3291, 1720, 1679 cm-1; 1H NMR (300  MHz, DMSO, 80 °C): δ 8.38 (bs, 1H), 7.61 
(d, J = 8.3 Hz, 2H), 7.40 (t, J = 7.7 Hz, 2H), 7.24 (t, J = 7.4 Hz, 1H), 6.28 (s, 1H), 4.83 (dd, J 
= 7.8 Hz, J = 2.3 Hz, 1H), 3.49-3.35 (m, 2H), 2.26-2.13 (m, 1H), 2.06-1.88 (m, 3H), 1.43 (s, 
9H), 1.37 (s, 9H); 13C NMR (75 MHz, DMSO, 80 °C): δ 153.6, 153.4, 153.1, 141.4, 130.0, 
128.0, 126.3, 123.8, 121.0, 107.2, 78.6, 78.3, 54.0, 45.7, 31.0, 27.7, 22.9; HRMS (ESI, m/z): 
Calcd. for C24H32N2O5Na: 451.2209, found [M+Na]
+: 451.2207; HPLC analysis (Chiralpak 
IA column, heptane/2-propanol = 95/5, flow rate = 1 mL/min, wavelength = 291 nm): Rt = 
10.55 (major) and 17.67 (minor). 
 
4.11 Typical procedure for O-debenzylation 
To a solution of furans 1a or 7 (0.2 mmol) in ethanol (2.4 mL) and cyclohexene (1.2 mL) 
was added 20% palladium hydroxyde on carbon (25% catalyst / substrate by weight). The 
suspension was stirred under reflux for 18 h. After cooling, the catalyst was filtered over a 
Celite plug, washed with dichloromethane and the volatiles were removed by evaporation in 
vacuo. The residue was purified by silica gel chromatography eluting with a mixture of 
cyclohexane / ethyl acetate / methanol (75 / 25 /1).       
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4.11.1 (S)-(1-(5-ethylfuran-2-yl)-2-hydroxyethyl)carbamic acid tert-butyl ester 13 
47 mg (93%), colorless oil; [α]D22= -51.1 (c 1.00, CH2Cl2), 96% ee; IR (UATR): 3396, 
1693 cm-1; 1H NMR (300  MHz, CDCl3): δ 6.13 (d, J = 3.1 Hz, 1H), 5.91 (d, J = 3.1 Hz, 1H), 
5.16 (bs, 1H), 4.82 (bs, 1H), 3.90 (dd, J = 11.2 Hz, J = 5.4 Hz, 1H), 3.83 (dd, J = 11.2 Hz, J = 
4.7 Hz, 1H),  2.61 (q, J = 7.5 Hz, 2H), 1.45 (s, 9H), 1.21 (t, J = 7.5 Hz, 3H); 13C NMR (75 
MHz, CDCl3): δ 157.8, 156.0, 150.3, 107.7, 104.7, 80.2, 64.9, 51.1, 28.5, 21.5, 12.1; HRMS 
(ESI, m/z): Calcd. for C13H21NO4Na: 278.1363, found [M+Na]
+: 278.1363; HPLC analysis 
(Chiralpak IA column, heptane/2-propanol = 97/3, flow rate = 1 mL/min, wavelength = 220 
nm): Rt =21.60 (minor) and 23.26 (major).             
                                                                                                                                         
4.11.2 (S)-(1-(5-ethyl-4-(4-fluorophenyl)furan-2-yl)-2-hydroxyethyl)carbamic acid tert-
butyl ester 14 
66 mg (94%), colorless oil; [α]D22= -49.4 (c 0.50, CH2Cl2), 97% ee; IR (UATR): 3410, 
1689 cm-1; 1H NMR (300  MHz, CDCl3): δ 7.32-7.25 (m, 2H), 7.11-7.03 (m, 2H), 6.32 (s, 
1H), 5.18 (bs, 1H), 4.88 (bs, 1H), 4.00-3.85 (m, 2H), 2.74 (q, J = 7.5 Hz, 2H), 2.14 (bs, 1H), 
1.47 (s, 9H), 1.25 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 161.8 (J1CF = 245.5 Hz), 
155.9, 152.5, 150.2, 130.0,  (J4CF = 3.3 Hz), 129.3 (J
3
CF = 7.8 Hz), 120.3, 115.6 (J
2
CF = 21.4 
Hz), 108.7, 80.3, 64.8, 51.1, 28.5, 20.4, 13.0;   HRMS (ESI, m/z): Calcd. for C19H24NO4FNa: 
372.1587, found [M+Na]+: 372.1585; HPLC analysis (Chiralpak IA column, heptane/2-
propanol = 95/5, flow rate = 1 mL/min, wavelength = 220 nm): Rt =15.26 (minor) and 17.42 
(major). 
 
4.12 (S)-2-Amino-2-(5-ethylfuran-2-yl)ethan-1-ol, hydrochloride 15 
To the product 13 (47 mg, 0.18 mmol) was added 4M HCl in dioxane (0.5 mL) and let stir 
for 1 h. The reaction mixture was concentrated in vacuo, taken up with a mixture of 
diethylether / ethyl acetate (4 / 1). The solid part was separated by filtration, washed with 
diethylether and dried in vacuum dessicator. Yield: 25 mg (72 %), beige solid, mp = 101-
102°C; [α]D22= -16.2 (c 0.50, MeOH); IR (UATR): 3550-2400 (broad), 2034   cm-1; 1H NMR 
(300  MHz, CD3OD): δ 6.43 (d, J = 3.2 Hz, 1H), 6.07 (d, J = 3.2 Hz, 1H), 4.41 (ABX System, 
JAX = 8.2 Hz, JBX = 4.9 Hz, 1H), 3.94 (ABX System, JAB = 11.6 Hz, JBX = 4.9 Hz, 1H), 3.88 
(ABX System, JAB = 11.6 Hz, JAX = 8.3 Hz, 1H), 2.66 (q, J = 7.5 Hz, 2H), 1.23 (t, J = 7.5 Hz, 
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3H); 13C NMR (75 MHz, CD3OD): δ 160.4, 146.9, 111.4, 106.3, 61.9, 51.9, 22.1, 12.5; 
HRMS (ESI, m/z): Calcd. for C8H11O2: 139.0759, found [M-NH3+H]
+: 139.0760. 
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